Dr. Haas is Founder, CEO and President of Cohen Veterans Bioscience, a non-profit biomedical and technology research organization based in New York City whose mission is to fast-track diagnostics and therapeutics to advance precision brain health. Dr. Haas is also the founder and co-lead of the Brain Health Nexus global initiative which seeks to establish new paradigm of global collaboration and unleash science and technology to optimize brain health and prevent brain disease through the establishment of a brain health index.  Magali has over 15 years of pharmaceutical executive experience, predominantly at Johnson & Johnson, where she assumed broad end-to-end development leadership roles in early & late-stage neuroscience clinical development, translational medicine, diagnostics and integrative solutions. She serves on several advisory boards including The European Platform for Neurodegenerative Diseases (EPND), Partnership for Assessment and Accreditation of Scientific Practice (PAASP), VirtualBrainCloud, Krembil Centre for Neuroinformatics and IMEC for nanoelectronics.  Magali earned her BS in bioengineering from the University of Pennsylvania, an MS in biomedical engineering from Rutgers University, and her MD and PhD in neuroscience with distinction from Albert Einstein College of Medicine.